Open AccessAptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients
Author(s) -
LiRong Yu,
Jinchun Sun,
Jaclyn R. Daniels,
Zhijun Cao,
Laura K. Schnackenberg,
Devasmita Choudhury,
Paul M. Palevsky,
Z. Jennie,
Richard D. Beger,
Didier Portilla
Publication year - 2018
Publication title -
kidney international reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.225
H-Index - 22
ISSN - 2468-0249
DOI - 10.1016/j.ekir.2018.04.012
Subject(s) - medicine , biomarker , dialysis , acute kidney injury , supar , kidney disease , fibroblast growth factor 23 , heart failure , proportional hazards model , gastroenterology , plasminogen activator , urokinase receptor , calcium , parathyroid hormone , biochemistry , chemistry
Currently, no effective therapies exist to reduce the high mortality associated with dialysis-dependent acute kidney injury (AKI-D). Serum biomarkers may be useful in understanding the pathophysiological processes involved with AKI and the severity of injury, and point to novel therapeutic targets.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom